As of Sep 25
| -0.02 / -1.71%|
The 1 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a -13.04% decrease from the last price of 1.15.
The current consensus among 1 polled investment analysts is to Hold stock in Ocera Therapeutics Inc. This rating has held steady since September, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.